{"disease":{"id":"draf-iii","name":"draf iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05979662","title":"Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Ibrahim Talal Elshamy","has_results":false},{"nct_id":"NCT05363423","title":"Lateral Pedicled Nasoseptal Flaps for Endoscopic Draf III Procedure in Patients With Frontal Sinus Inverted Papilloma","phase":"","overall_status":"UNKNOWN","enrollment_count":22,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}